9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid

1. Innate Mucosal Immunity in the Oral Cavity

The Epithelial Barrier: Architectural Specialisation

The oral mucosa presents three distinct gingival epithelial phenotypes, each adapted to distinct mechanical and immunological demands:

The junctional epithelium (JE) forms the anatomical attachment between the gingiva and the calcified tooth surface (directly attached to the tooth, DAT) via hemidesmosomes and an internal basal lamina. Because its cells are oriented parallel to the tooth surface and express fewer desmosomal junctions, the intercellular spaces occupy up to 18% of the tissue volume. This permeable architecture serves as a high-flow transit corridor, facilitating the constant forward percolation of gingival crevicular fluid (GCF) into the sulcus and the reciprocal trans-epithelial migration of host immune cells toward the subgingival biofilm.

Junctional epithelial cells constitutively express intercellular adhesion molecule-1 (ICAM-1 / CD54) and secrete the chemokine CXCL8 (IL-8) in response to bacterial lipopolysaccharide (LPS). This establishes an immobilized haptotactic gradient that directs migrating polymorphonuclear leukocytes (PMNs) directly into the gingival crevice.

Antimicrobial Peptides (AMPs)

Antimicrobial peptides represent ancient effector molecules synthesized by oral keratinocytes and recruited phagocytes:

• Human Beta-Defensins (hBDs): Small, cationic, cysteine-rich peptides containing three intramolecular disulfide bonds.
  • hBD-1: Constitutively expressed by suprabasal stratified squamous cells throughout the oral mucosa, providing persistent baseline surveillance.
  • hBD-2 and hBD-3: Strongly inducible in response to pro-inflammatory stimuli (TNF-α, IL-1β) and Gram-negative bacterial lipopolysaccharide via Toll-like receptors (TLR2 and TLR4). They disrupt microbial cell membranes via pore formation and function as chemoattractants for immature dendritic cells and memory T lymphocytes through chemokine receptor CCR6.
• Alpha-Defensins (Human Neutrophil Peptides HNP-1 to HNP-4): Stored in the azurophilic granules of neutrophils and released directly into the gingival crevice during degranulation or NETosis.
• Cathelicidin (LL-37 / hCAP-18): Synthesised as an inactive precursor (hCAP-18) and cleaved into the active 37-amino acid peptide LL-37 by neutrophil proteinase 3. LL-37 exerts broad-spectrum bactericidal activity against subgingival anaerobes, neutralises bacterial LPS to curb endotoxic shock, and promotes re-epithelialisation.

[!IMPORTANT] Clinical Relevance — Papillon-Lefèvre Syndrome: Papillon-Lefèvre syndrome is an autosomal recessive disorder caused by loss-of-function mutations in the CTSC gene encoding cathepsin C (dipeptidyl peptidase I). Cathepsin C is required to remove the N-terminal pro-peptides to activate neutrophil serine proteases, including proteinase 3, elastase, and cathepsin G. In the absence of functional proteinase 3, hCAP-18 cannot be processed into active LL-37. This selective molecular failure leads to catastrophic, prepubertal periodontitis resulting in early loss of both deciduous and permanent dentitions, combined with severe palmoplantar hyperkeratosis.

Gingival Crevicular Fluid (GCF) Dynamics

In absolute health, GCF is an interstitial transudate produced at minimal rates (0.2–0.5 µL/hour). With the onset of biofilm-induced subclinical inflammation, microvascular permeability within the gingival plexus increases dramatically, transforming GCF into an inflammatory exudate whose flow rate increases more than five-fold (>1.5–3.5 µL/hour).

GCF fulfills dual protective roles:

1. Mechanical flushing: Continual outward hydrokinetic flow retards the inward penetration of non-adherent planktonic bacteria into the subgingival pocket.
2. Biochemical and cellular defence delivery: GCF delivers serum-derived complement proteins (C3, C4, C5), specific immunoglobulins (predominantly IgG1 and IgG2 subclasses), transferrin, lactoferrin, and active host leukocytes—of which viable neutrophils constitute over 90–95%.

---

The Junctional Epithelium as a Controlled Weak Point

The junctional epithelium is where the body's surface is deliberately interrupted to let a hard tissue through, and almost everything about periodontal disease follows from that compromise. It is non-keratinised, has wide intercellular spaces and comparatively few desmosomes, and it attaches to the tooth by a hemidesmosome–basal lamina complex. Those features make it permeable in both directions: bacterial products pass inwards, and neutrophils and gingival crevicular fluid pass outwards. Turnover is rapid — of the order of four to six days — which is itself a defence, because infected superficial cells are shed into the sulcus. The examinable consequence is that the junctional epithelium is simultaneously the principal portal of entry for periodontal pathogens and the principal exit route for the host's cellular defence.

Gingival Crevicular Fluid as a Diagnostic Window

Gingival crevicular fluid is a serum transudate in health and becomes an inflammatory exudate in disease, and its volume increases in proportion to the degree of inflammation. Because it carries host enzymes and mediators, it has been extensively investigated as a diagnostic sample — matrix metalloproteinase-8, interleukin-1β and aspartate aminotransferase are the markers most often cited. The examinable caution is that no gingival crevicular fluid marker has replaced probing and radiographs in routine practice; site-specific diagnosis of periodontitis in the UK remains clinical, based on interdental clinical attachment loss and radiographic bone loss.